Santiago

As a premier gateway to Latin America, Santiago, Chile, has emerged as a high-growth life sciences ecosystem characterized by robust biotechnology research and a sophisticated pharmaceutical manufacturing base.

The city is globally recognized for its healthcare innovation, particularly in the development of advanced cell therapies and sustainable biotech startups that leverage Chile's unique natural resources.

Leading academic research institutions, such as Pontificia Universidad Católica de Chile, drive the sector forward through translational medicine and high-impact international collaborations.

Santiago’s favorable regulatory environment, overseen by the Instituto de Salud Pública (ISP), makes it an attractive destination for clinical trials and the commercialization of medical devices.

The region is a burgeoning hub for digital health solutions and AI-powered drug discovery, attracting significant venture capital and public funding from agencies like CORFO.

Multinational pharma giants and agile medtech companies benefit from the city's modern infrastructure and its strategic role as a regional distribution center.

By fostering a "One Health" approach, Santiago integrates animal and human health research to address global challenges like antibiotic resistance and neurodegenerative diseases. This vibrant innovation hub continues to bridge the gap between scientific discovery and global market entry.

Recent milestones in technology transfer highlight the city’s capacity to export world-class medical breakthroughs to international markets.

Consequently, Santiago stands as a top-tier destination for investors seeking a stable yet dynamic life sciences environment in the Southern Hemisphere.